Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Catalent, Inc. | Director | Common Stock | 12.6K | $758K | $59.97 | Oct 30, 2024 | Direct |
Crinetics Pharmaceuticals, Inc. | Director | Common Stock | 9.4K | $446K | $47.49 | Jun 7, 2024 | Direct |
PTC THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 10K | $271K | $27.05 | Feb 15, 2024 | Direct |
PTC THERAPEUTICS, INC. | Director | Common Stock | 9.87K | $269K | $27.25 | Feb 15, 2024 | Direct |
Crinetics Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 12.5K | Jun 7, 2024 | Direct | ||
ALBIREO PHARMA, INC. | Director | Stock Option (right to buy) | 0 | Mar 2, 2023 | Direct |